How Hospitals Evaluate New Vendors and What It Takes to Get Approved

Getting a product approved for use in a hospital is one of the most structured and demanding processes in commercial healthcare. For manufacturers and sales organizations unfamiliar with how it actually works, the experience can feel opaque, slow, and frustrating. For those who understand the process, it is navigable and the outcome, a place on the approved vendor list, is enormously valuable.

Understanding how hospitals evaluate new vendors equips manufacturers and their distribution partners to prepare the right materials, engage the right people, and move through the process efficiently.

The Value Analysis Committee Is the Decision-Making Body

In most hospital and health system settings, the formal body responsible for evaluating new products and vendors is the Value Analysis Committee, commonly referred to as the VAC. This committee typically meets on a scheduled basis and evaluates new product submissions against a defined set of criteria.

VAC membership varies by institution but generally includes clinical representatives from the relevant specialty, supply chain and procurement leadership, finance and budget personnel, infection control staff where relevant, and sometimes risk management representatives. Each of these stakeholders evaluates the product through a different lens, and a successful submission addresses all of them.

What the Committee Evaluates

The clinical evidence for the product is the starting point. The committee will want to see peer-reviewed studies, clinical outcomes data, and if available, comparisons to the current standard of care or the product currently in use. The evidence should be organized in a format that is easy to review and directly relevant to the clinical setting of that specific institution.

Financial analysis is equally important. The committee will evaluate total cost of ownership, not just unit price. This includes implementation costs, training requirements, any operational efficiency impact, and where applicable, the reimbursement implications for the institution. Presenting a clear and honest financial case significantly accelerates the evaluation process.

Operational considerations including storage requirements, shelf life, implementation timeline, and the level of vendor support provided during rollout are also reviewed. The committee wants to know that adopting this product will not create operational disruptions that outweigh its clinical benefits.

The Role of the Clinical Champion

No product advances through a hospital evaluation process without at least one internal clinical champion: a physician, nurse, or clinical administrator who believes in the product and is willing to advocate for it within the institution.

Identifying and developing this champion before the formal submission process begins is critical. A champion who can speak to the product's clinical value from personal experience or direct evaluation carries far more weight with the committee than any manufacturer-provided documentation. Without a champion, most products never make it to a formal evaluation.

What Gets Products Rejected

Understanding common rejection reasons helps vendors avoid them. Products are most commonly rejected or tabled because the clinical evidence is insufficient or not relevant to the institution's patient population, the financial case is unclear or does not hold up under scrutiny, a clinical champion with sufficient internal influence has not been developed, the submission is incomplete or does not address all committee criteria, or a competing product already on the formulary performs adequately and the switching cost is not justified.

Addressing each of these proactively, rather than reactively after a rejection, dramatically improves approval rates.

How DAVAB Health Systems Navigates the Approval Process

At DAVAB Health Systems, our team has extensive experience preparing and presenting product submissions to hospital value analysis committees. We know what documentation is required, what financial arguments resonate, and how to develop the clinical champions who make approval possible.

If you are a manufacturer looking to get your product approved in hospital accounts and want a partner who knows how to navigate this process, we want to talk. Email us at sales@davabhealth.com to start the conversation.